These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17446800)

  • 1. Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the CARDIA Study.
    Iribarren C; Husson G; Sydow K; Wang BY; Sidney S; Cooke JP
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):222-9. PubMed ID: 17446800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients.
    Coen G; Mantella D; Sardella D; Beraldi MP; Ferrari I; Pierantozzi A; Lippi B; Di Giulio S
    J Nephrol; 2009; 22(5):616-22. PubMed ID: 19809994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.
    Maas R; Wenske S; Zabel M; Ventura R; Schwedhelm E; Steenpass A; Klemm H; Noldus J; Böger RH
    Eur Urol; 2005 Dec; 48(6):1004-11; discussion 1011-2. PubMed ID: 16139418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virus.
    Jang JJ; Berkheimer SB; Merchant M; Krishnaswami A
    Atherosclerosis; 2011 Aug; 217(2):514-7. PubMed ID: 21549379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum magnesium is inversely associated with coronary artery calcification in the Genetics of Atherosclerotic Disease (GEA) study.
    Posadas-Sánchez R; Posadas-Romero C; Cardoso-Saldaña G; Vargas-Alarcón G; Villarreal-Molina MT; Pérez-Hernández N; Rodríguez-Pérez JM; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG; Torres-Tamayo M
    Nutr J; 2016 Mar; 15():22. PubMed ID: 26931571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery calcification at electron beam computed tomography is increased in asymptomatic type 2 diabetics independent of traditional risk factors.
    Wolfe ML; Iqbal N; Gefter W; Mohler ER; Rader DJ; Reilly MP
    J Cardiovasc Risk; 2002 Dec; 9(6):369-76. PubMed ID: 12478207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma leptin levels and coronary artery calcification in older adults.
    Iribarren C; Husson G; Go AS; Lo JC; Fair JM; Rubin GD; Hlatky MA; Fortmann SP
    J Clin Endocrinol Metab; 2007 Feb; 92(2):729-32. PubMed ID: 17148566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: A meta-analysis based on 4713 participants.
    Xuan C; Tian QW; Li H; Zhang BB; He GW; Lun LM
    Eur J Prev Cardiol; 2016 Mar; 23(5):502-10. PubMed ID: 25956428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of coronary artery calcium in young adults using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) risk score: the CARDIA study.
    Gidding SS; McMahan CA; McGill HC; Colangelo LA; Schreiner PJ; Williams OD; Liu K
    Arch Intern Med; 2006 Nov; 166(21):2341-7. PubMed ID: 17130387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between coronary atherosclerotic burden and asymmetric dimethylarginine, carotis intima media thickness and endothelial function.
    Can F; Ziyrek M; Erdem Ş; Civan M; Görmüş U; Şahin S; Acar Z; Çiftçi Ç
    Turk Kardiyol Dern Ars; 2014 Dec; 42(8):701-9. PubMed ID: 25620330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study.
    Yan LL; Liu K; Daviglus ML; Colangelo LA; Kiefe CI; Sidney S; Matthews KA; Greenland P
    JAMA; 2006 Apr; 295(15):1793-800. PubMed ID: 16622141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White blood cell count in young adulthood and coronary artery calcification in early middle age: coronary artery risk development in young adults (CARDIA) study.
    Hou L; Lloyd-Jones DM; Ning H; Huffman MD; Fornage M; He K; Zhang X; Jacobs DR; Goff DC; Sidney S; Carr JJ; Liu K
    Eur J Epidemiol; 2013 Sep; 28(9):735-42. PubMed ID: 24030512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk.
    Kullo IJ; Li G; Bielak LF; Bailey KR; Sheedy PF; Peyser PA; Turner ST; Kardia SL
    Mayo Clin Proc; 2006 Feb; 81(2):177-82. PubMed ID: 16471071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study.
    Schulze F; Lenzen H; Hanefeld C; Bartling A; Osterziel KJ; Goudeva L; Schmidt-Lucke C; Kusus M; Maas R; Schwedhelm E; Strödter D; Simon BC; Mügge A; Daniel WG; Tillmanns H; Maisch B; Streichert T; Böger RH
    Am Heart J; 2006 Sep; 152(3):493.e1-8. PubMed ID: 16923419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between plasma asymmetrical dimethylarginine and coronary artery disease].
    Song Y; Qu XF; Yu YW; Luan TZ; Li JJ; Guo H; Yu Y
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1527-30. PubMed ID: 17785101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis.
    Elesber AA; Solomon H; Lennon RJ; Mathew V; Prasad A; Pumper G; Nelson RE; McConnell JP; Lerman LO; Lerman A
    Eur Heart J; 2006 Apr; 27(7):824-31. PubMed ID: 16434411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric dimethylarginine and coronary collateral vessel development.
    Kocaman SA; Sahinarslan A; Biberoglu G; Hasanoglu A; Akyel A; Timurkaynak T; Cengel A
    Coron Artery Dis; 2008 Nov; 19(7):469-74. PubMed ID: 18923242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
    Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticalcifying nanoparticle antibody titer is an independent risk factor for coronary artery calcification.
    Tulunay Kaya C; Sinan Ertas F; Hasan T; Candemir B; Ozdol C; Arikan Akan O; Kocum T; Dincer I; Sahin M; Atmaca Y; Conkbayır C; Erol C
    Coron Artery Dis; 2011; 22(6):394-400. PubMed ID: 21709548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.